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The partial amino acid sequences of cyanogen bromide peptides of endoglucanase II, 1,4-fl-glucan 
glucanohydrolase (from Trichoderma reesei) were determined by automated Edman degradation with 
liquid and solid phase techniques. Computer programs for finding distant relationships between the two 
amino acid sequences were used to compare the partial sequences of endoglucanase II with the complete 
sequence of cellobiohydrolase I. Homologous regions were found for all the cyanogen bromide peptides. 
Cellulase Endoglucanase Trichoderma reesei Amino acid sequence Homology 
1. INTRODUCTION 
The fungus Trichoderma reesei is probably the 
most efficient cellulolytic organism known so far. 
This is due to its ability to produce large quantities 
of cellulases, mainly of two types, 1,4-&glucan 
glucanohydrolases and 1,4-fl-glucan cellobiohy- 
drolases. This classification is based on experi- 
ments using different cellulose derivatives as 
substrates and it is doubtful whether it defines 
their specificity on native cellulose, where 
synergistic effects between endoglucanases and 
cellobiohydrolases and between two different 
cellobiohydrolases is a dominating phenomenon. 
The difference between the two categories of en- 
zymes is nevertheless evident. The endoglucanases 
attack cellulose derivatives and have a low affinity 
for crystalline cellulose, while the opposite is true 
for the cellobiohydrolases. This work has been 
Abbreviations: endo II, 1,4-&glucan glucanohydrolase 
(EC 3.2.1.4); CBH I, 1 &,&glucan cellobiohydrolases 
(EC 3.2.1.91); HPLC, high-performance liquid chroma- 
tography; RCM, reduced and carboxymethylated 
undertaken as a first approach to elucidate the 
structural differences between the two classes of 
cellulases. We have thus compared the partial 
amino acid sequences of the CNBr fragments of an 
endoglucanase (endo II) with the complete se- 
quence of a cellobiohydrolase (CBH I) using a 
computer program to evaluate homologies. 
Due to the technical potentialities of cellulases 
many groups have started cloning experiments 
[2,3] and it is our hope that partial amino acid se- 
quences will facilitate this research and that the 
complete amino acid sequence of the enzyme will 
be determined in the near future from the 
nucleotide sequence of the gene. We are convinced 
that the combination of the conventional tech- 
nique and the recombinant DNA technique will be 
the method of choice for sequencing the highly 
glycosylated cellulases . 
2. MATERIALS AND METHODS 
2.1. Materials 
Freeze-dried culture filtrates of T. reesei 
QM 9414 were a gift from Dr M. Mandels, US Ar- 
my Natick Research and Development Command, 
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Natick, MA. Endo II was isolated and further 
purified by ion-exchange chromatography as in 
t4,51. 
All chemicals and proteolytic enzymes were 
commercially obtained in the most pure form. 
2.2. Methods 
Reduction and carboxymethylation, CNBr 
cleavage [6,7], staphylococcal protease and car- 
boxypeptidase A digestion were performed as in 
[ 11. Deblocking of N-terminal amino acid by 
pyroglutamyl aminopeptidase was performed as in 
[81. 
2.3. Separation of peptides by reversed-phase 
HPLC 
Peptide separations were performed on an Altex 
model 110 chromatography system (two model 
110 A pumps, model 410 solvent programmer, a 
Rheodyne model 7120 sample injector with a 
230~1 sample loop, LDC Spectromonitor III and 
Gilson minicol TDC fraction collector). 
Peptides were chromatographed on either a 
4.5 x 250 mm Lichrosorb RP 8, 7,~ or Spherisorb 
ODS lo/c column, equilibrated in 5 mM am- 
monium acetate buffer (pH 6.4). Peptides were 
eluted with a linear gradient of one of the follow- 
ing organic solvents: 70% ethanol, 70% 
I-propanol or a mixture of l-propanol:methox- 
yethanol : water (70 : 5 : 25). After pooling the ap- 
propriate fractions spectra were recorded and ali- 
quots were taken for amino acid analysis. 
2.4. Amino acid analysis 
Samples were hydrolyzed in evacuated and 
sealed tubes for 24 h at 110°C with 6 M HCl con- 
taining 2 mg/ml phenol. After evaporation, the 
hydrolysates were analyzed with a Durrum-500 
analyzer. Serine and threonine values were 
calculated using the standard recovery factors of 
0.90 and 0.96, respectively. 
2.5. Sequence determination 
Manual Edman degradation was performed as 
in [9] but phenylthiohydantoin (PTH) derivatives 
of the released amino acid were identified by 
HPLC as described below. 
Solid-phase sequencing was carried out in an 
LKB 4020 sequencer. Peptides were coupled by 
either the homoserine lactone method [lo] or the 
302 
carbodiimide method [ 111. For liquid-phase se- 
quencing, a Beckman 890 C sequencer (Beckman 
Instruments, Palo Alto) with Beckman program 
122974 was used. 
The PTH derivatives of amino acids were 
analyzed on a reversed-phase column (0.4 x 
30 cm) of Nucleosil Cl8 (5~) using a linear gra- 
dient elution method with acetonitrile as organic 
solvent and 5 mM sodium acetate (pH 5) as the 
aqueous medium. 
Concentration of aqueous medium, gradient, 
time and temperature were adjusted to obtain bet- 
ter separation of all PTH amino acids. The condi- 
tions most often used for a complete run of 27 min 
were: a 12-min linear gradient from 20 to 48% 
acetonitrile at 35°C. 
2.6. Homology calculations 
Alignment of sequences and scores for best 
alignment were obtained with a computer program 
based on the algorithm in [12]. Weights (scores) 
for amino acid pairs were taken from the table in 
[13] giving the relatedness odds matrix for 
256 PAM (accepted point mutations per 100 
residues) suitable for the detection of distant rela- 
tionships. Each value was increased by 78 in order 
to avoid negative scores, as required by the 
algorithm. For each alignment a total score was 
calculated. The above chance similarity of two se- 
quences, also called the alignment score, was the 
deviation of the total score for the comparison of 
the two real sequences from the mean score of the 
comparisons of 50 random sequences of the same 
composition [ 121. The alignment score was ex- 
pressed in standard deviation units (SD). 
To find the best fit of a short sequence when 
compared to a much longer sequence, the follow- 
ing procedure was used. The short sequence was 
compared to segments of equal length along the 
entire longer sequence and values of total score 
were plotted against residue number of the longer 
sequence. For the short stretches of the longer se- 
quence where only composition was available, 
composite sequence was used. In this each position 
contained all residues occurring in the non- 
sequenced part. The weight for a position in the 
comparison was then calculated as the mean of all 
possible pairs. Finally an alignment score was 
calculated for the alignment with highest total 
scores in the study. 
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Alignment score, expressed in SD units, 
estimates the relatedness of two sequences: > 10 
SD units indicates strong homology; 3- 10 SD units 
indicates a distant but still significant evolutionary 
relationship; 2-3 SD units indicates a potential 
homology [14]. 
3. RESULTS 
3.1, Amino acid composition, N-terminal and 
C-terminal residues 
determine, since the carbohydrate composition is 
unknown. Carbohydrate analysis indicated the 
presence of mannose, glucose and glucosamine. 
Since no N-terminal amino acid was detected by 
the Edman method, the N-terminus seemed to be 
blocked. After treatment with calf liver 
pyroglutamyl aminopeptidase, automated se- 
quence analysis on the RCM protein gave 24 
residues from the N-terminal. Incubation with car- 
boxypeptidase A gave leucine as the C-terminal. 
The M, of the peptide chain was estimated to be 3.2. Preparation and analysis of peptides 
47000 by normalizing the amino acid composition The RCM protein was subjected to CNBr 
(table 1) of the RCM protein to 9 lysine residues. cleavage. The digest was separated into 7 peaks by 
The M, of the whole glycoprotein was difficult to gel filtration (fig.1). The peaks were denoted 
Table 1 
Amino acid composition of reduced and carboxymethylated protein, cyanogen bromide peptides and two peptides of 
S-protease digest 
CNBr peptides of endo II Endo II S-protease 
peptides 
CNII CN CN VB VC VD VIA VIBVIIAVIIB C B A GL VII GL IX 
III IV D H 
CM-Cys 
Asp 
Thr 
Ser 
Glu 
Pro 
Gly 
Ala 
Val 
Met 
Is0 
Leu 
TYr 
Phe 
His 
LYS 
Trp* 
Arg 
Hser 
Glucos- 
amine 
Total 
3.1(3) 2.2(2) 3.7(4) 3.5(4) 3.9(4) 2.2(2) - 0.9(l) - - 20 20 5.0 
13.6(14) 7.9(8) 7.9(8) 8.6(9) 3.1(3) 3.3(3) 2.2(2) 4.2(4) 1.2(l) - 52 55 12.7 
16.1(16) 6.9(8) 6.5(6) 4.3(4) 4.0(4) 6.8(7) - - - - 44 44 10.2 
19.0(19) 6.9(7) 5.0(5) 2.8(3) 4.1(4) 4.0(4) 6.7(7) 4.1(4) - 2.1(2) 55 58 13.5 
5.8(6) 3.7(4) 2.6(3) 7.0(7) 3.6(4) 4.5(4) 1.4(l) 4.1(4) 1.0(l) - 34 30 7.0 
8.0(8) 3.3(3) 1.0(l) 1.2(l) 1.1(l) 3.1(3) 1.8(2) 1.0(l) - - 20 24 5.6 
12.4(12) 7.6(7) 6.0(6) 7.3(7) 6.3(6) 4.2(4) 3.6(3) 3.0(3) - 2.3(2) 50 47 11.0 
5.0(5) 4.3(4) 3.8(4) 4.0(4) - 1.8(2) - 1.1(l) - 1.1(l) 21 25 5.9 
2.1(2) 3.0(3) 3.6(4) 1.2(l) - 3.9(4) 2.0(2) 1.1(l) - - 17 19 4.5 
- - - - - _ - - _ _ 
4.0(4) 2.1(2) 1.2(l) - 1.0(l) - - - - - s 
9 2.2 
3.3(3) 2.5(2) 2.0(2) 1.2(l) 1.3(l) 2.4(2) 3.1(3) 6.8(7) - 1.1(l) 22 f; 
2.9 
5.4 
3.9(4) 3.2(3) 1.8(2) 2.7(3) 3.7(4) 1.6(2) 2.8(3) 1.1(l) 1.0(l) - 23 23 5.3 
2.2(2) 1.5(2) 0.8(l) 0.8(l) - - - 1.1(l) - - 7 9 2.2 
2.3(2) 0.9(l) 1.0(l) 0.8(l) - 1.0(l) - - - 6 2.0 
1.2(l) 2.0(2) 1.0(l) - 0.9(l) 3.0(3) - 1.0(l) - 1.&l) 1: 9 2.1 
- - - - - - - - _ _ 7 1.6 
2.5(2) 0.6(l) - 0.8(l) - - 0.9(l) - - - I 1.8 
(1) (1) (1) (1) 0 - (1) (1) (1) (1) 8 _7 - 
3.2(3) 
7.0(7) 
3.8(4) 
1.7(2) 
2.2(2) 
1.1(l) 
3.4(3) 
2-o(2) 
1.9(2) 
0.3(l) 
1.0(l) 
1.2(l) 
2.0(2) 
0.9(l) 
0.9(l) 
1 *o(l) 
2.8(3) 
1.0(l) 
- 
1.2(l) 
- 
+ + + + - - - - - - + + + 
104 59 50 48 33 41 25 30 4 8 402 420 100 
0.7(l) 
38 
- 
10 
a Determined spectrophotometrically 
Results are given as residues per molecule. Values in parentheses are nearest integer. A, mole percent amino acid 
composition of endo II; B, amino acid composition of endo II normalized to lysine = 9; C, sum of all CNBr fragments 
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Fig. 1. Elution profile of the CNBr-generated peptides of 
endo II. The column of Sephadex G-50 superfine (150 x 
1.5 cm) was in 0.05 M HCI acid. Fractions of 2.9 ml (95 
drops) were collected at a flow rate of 12 ml/h. (0) 
Azso, (m) A280. 
CN I-CN VII in order of elution. CN I and CN II 
were further purified on a Sephadex G-75 column. 
CN III was rechromatographed on G-50 and 
showed the same amino acid composition as CN I. 
The identity of the two peptides was further sup- 
ported by the fact that CN III and CN I had the 
same elution positions when chromatographed in 
an alkaline medium. CN IV-CN VII were further 
fractionated by HPLC. The subfractions obtained 
were denoted by capital letters. In many cases 
poorly resolved double peaks with identical amino 
acid compositions were obtained, which may in- 
dicate heterogeneity in glycosylation or incomplete 
conversion of homoserine lactone to homoserine. 
A total of 10 peptides were recovered. When 
several peptides had the same amino acid composi- 
tion, only one of them is reported (table 1). Two 
peptides, CN V C and CN V D did not contain 
homoserine. One of them is presumed to be the C- 
terminal peptide and the other must be the result of 
an atypical cleavage. Three peptides, namely, 
CN II, CN IV and CN V B contained car- 
bohydrate as indicated by the presence of 
Table 2 
Alignment scores of CNBr peptides of endo II, which gave high total score values 
in the computer runs, and residue numbers of CBH I which aligned with these 
peptides 
Peptides 
of endo II 
Number of 
amino acids 
compared 
Residue no. 
of CBH I 
Total 
score 
Alignment 
score 
CN II 25 15- 39 2282 3.0 
38- 62 2325 2.6 
370-393 2350 3.3 
CN III 20 49- 69 1683 3.2 
209-228 1932 6.4 
GL VII D 17 38- 55 1679 2.1 
258-274 1703 3.1 
11 38- 49 3.0 
CNVB 20 145-167 2287 6.5 
318-338 1829 2.3 
CNVC 27 235-265 2911 2.5 
(C-terminal) 460-486 3822 8.2 
CN VI 51 90-141 5483 11.0 
CNVD 26 l- 26 2529 3.7 
(N-terminal) 147-172 2301 2.2 
301-326 2313 3.5 
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glucosamine. To obtain overlapping sequences, an 
S-protease digest was fractionated and purified in 
the same way as the CNBr peptides. Only two 
methionine-containing peptides are reported here 
(GL VII D and GL IX H). Their amino acid com- 
positions are shown in table 1. 
3.3. Fbrtial sequences of CNBr peptides 
Fig.2 shows the partial amino acid sequences of 
the 10 CNBr peptides resulting from cleavage at 
the 9 methionine residues present in the intact pro- 
tein. From its amino acid composition, CN V D 
was assigned to the N-terminus of the molecule. By 
coupling this peptide to aminopropyl glass with the 
carbodiimide method and treatment with trypsin, 
the sequence after Lys-20 could be determined. In 
many cases, repetitive yields were low, probably 
due to the fact that the peptides are glycosylated. 
The sequence of S-protease peptide GL VII D pro- 
vided the overlap on the N-terminal side of CN IV 
CN II 
CN III 
GL VIID 
CN IV 
CN V E 
CN V C ft-terl 
CN V D IN-ter) 
CN VI A 
CN VI B 
GL IX H 
CN VII A 
CN VII 8 
NWLDGGNAGPCSTPEGTPSILANCPl78 residues)M 
+------+A 
DILEGNSRAXALTXHSNVATf36 residues)M 
----,--h 
UNVRWMHDANVNSSDVV(20 residues)E/D 
777 
HDANVNSSDVV(38 residues)M 
_I 
DENGGANQVNTAGANVGSGVXXAQ(23 residues)M 
-+__) 
GQCGGIGVSGCKTCTSGTTCQVSNXXVSQf4 residues)L 
+ + - -mc 
Pyr-EPGTSTPEVHPKLTTVKCTKNGGCVAll5 residues) 
-+77 
PSSSGGVSSVSPRLVLLDSDGEVVM 
-B__) 
LKLNGQELSFDVDLSALPCGENGSLVISZLIH 
VVMLKL(NGQlE 
7 
OQVH ___ 
GKALSSGR 
-7 
Fig.2. Sequence determination of CNBr and S-protease 
peptides of endo II. Residues are identified by liquid- 
phase sequencer (-), solid-phase sequencer (- ) 
and manual Edman degradation (-- -). 
peptide, whereas GL IX H bridged CN VI A and 
CN VI B. 
3 4. Homology calculations 
The partial sequences of the CNBr peptides of 
endo II were compared with the sequence of 
CBH I. Positions for the best alignments and their 
total scores and SD values are reported in table 2. 
Fig.3 shows the alignment of endo II peptides 
along the complete sequence of CBH I. CN VI A 
and CN VI B were treated as a single peptide 
(CN VI) since they could be aligned. The best 
alignment score was used to allocate the peptides. 
For two peptides (CN V C and CN VI) over- 
whelming evidence for homology was found 
(alignment score: 8.2 and 11 .O). In two cases 
(CN II and GL VII D), alternative alignments with 
comparable score were obtained. In these cases cir- 
cumstantial evidence was used to decide the loca- 
tion. CN V D was thus assumed to be the N- 
terminal peptide. CN II had one possible location 
in the N-terminal region which, however, was 
already occupied by CN V D. The second alter- 
native (370-393) was thus assumed for CN II. 
GL VII D was located on the basis of the amino 
acid compositions of the total set of S-protease 
peptides and CNBr peptides and partial sequences 
of some of S-protease peptides (unpublished). 
Here it should be observed that the occurrence of 
two possible alignments with rather high score for 
a peptide may reflect the presence of internal 
duplication. 
4. DISCUSSION 
Endo II and CBH I are extracellular enzymes. 
Both have lo-12 disulphide bridges, which give 
the protein stability and a compact structure. Both 
have pyroglutamic acid as the N-terminal amino 
acid and leucine as C-terminal. By visual inspec- 
tion of the partial sequences of the CNBr peptides 
of endo II, strong homology was observed in one 
region beginning around residue 100 and also in 
the C-terminal region. Although the rest of the 
peptides did not show any apparent homology they 
could nevertheless be aligned along the CBH I se- 
quence using the computer programs. According 
to our results the two enzymes do not seem to have 
any common antigenic determinants [5]. Recently, 
however, results have been presented which con- 
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CBH I 
END0 II 
CBH I 
EN00 II 
tCN IV 
i 
NTWSSTLCPONETCAKiCCLOGAAY~TSAY~ (SSZPVVGGGGGIFFK)NV% -_-- --------------- 
Q PSSSGGYS VS 
e-CW VI A- 
CBH I 
EN00 II 
CBH I 
EN00 II 
-CC V,B 
CBH I 
EN00 II 
CBH I 
CBH I DDGVTFQQPNAELGSYSGNELNDDYCTAEEAEFGGSSFSDKGGLTQF(XX)~So 
CBH I 
EN00 II 
d-CN II 
CBH I 
: 
QVESQSPNAKVTFSNIKFGPIGSTGNPSGGNPPGGNPPE(~~~Q~ 
CBH I 
EN00 II 
1 U’ u 
l CN V C 
Fig.3. Alignment of CNBr peptides of endo II with complete sequence of CBH I. Sequence identities are boxed. A gap 
(-) is inserted to obtain homology. Underlined (---) are unsequenced fragments with known amino acid 
composition. 
tradict this statement [15]. Although we only have 
partial sequences of endo II it may be concluded 
that the extent of homology between the enzymes 
is so evident that the two enzymes certainly have a 
common origin and that the chain folding is 
similar. 
The available partial sequences of other sac- 
charifying enzymes from different organisms were 
also compared with the cellulases. Comparison 
was done in the same manner as previously 
described. Fig.4 shows some sequences where high 
total scores and alignment scores were obtained. 
No amino acid sequence data for the ,& 
glucosidases from T. reesei are available, but the 
amino acid sequence of a tryptic glycopeptide (63 
residues) from the active site of a ,&glucosidase 
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GLUCO 
CBH I 
1116-169) 
GLUCO 
CBH I 1356-373) 
XYLANASE (N-TERMINAL) 
CBH I 1130-144) 
LYS (2-38) 
CBH I 1129-167) 
1.3; 1,4- -Glucan 
ENDOHYDROLASE 
CBH I (267-306) 
(2.8 SD) 
(4.36 SD) 
V E-RCELARTLKRLGMDG,YRGIS-LANMMCLAKUESGY 
[? [10 L] 1 31 0 [I 
VSQLPCGLNGALYFVSMDADGGVS YPTNTAGAKYGTGY 
(3.66 SD) 
IGVXYGMSAN-NLPAA-S-TVV M KSNGINSMRLYAPDQAAL 
u 0 B B n uu u 
-SF-YGPGSSFTLDTTKKLTVV QFETSGIN--RYYVQDGVTF 
(4.48 SD) 
Fig.4. Alignment of sequences from different saccharifying enzymes with CBH I and SD values in parentheses. 
Sequence identities are boxed. GLUCO, fl-glucosidase; LYS, human lysozyme. 
from Aspergilfus wentii [la] gave high total scores quence data are necessary to make any comment 
with two regions in CBH I. Only one of them on the relation between the presence of an intron 
(CBH I 116-169) gave a high alignment score. and similarity in amino acid sequence in the region 
Visual inspection of the second alternative of the exon-intron junction. The N-terminal of 
(350-412), revealed that the first 18 residues from 1,3 ; 1,4 ,&glucan endohydrolase from germinating 
the N-terminus, including a catalytically active barley [ 181 showed significant evolutionary rela- 
aspartic acid residue, showed similarity (fig.4). It tionship with CBH I in the region 267-306. The 
should be observed that the catalytically active sequence from Glu-33 to Tyr-51 of endo-p-1,4 
aspartic acid residue in the ,&glucosidase is re- glucanase from S. commune [19] has been 
placed by a leucine residue in CBH I but two reported. It shows homology with the active site se- 
aspartic acid residues are only two positions ahead quences of various hen egg-white type lysozymes. 
in the CBH I sequence. The question is whether No homology of this type was observed with 
one of them might be catalytically active. CBH I or endo II. 
Endo II has been reported to show xylanase ac- 
tivity and hence it was compared with the available 
N-terminal sequence of a true xylanase from 
Schizophyilum commune [ 171, and a potential 
homology was found in the region from position 
130 and onwards of CBH I. Lysozyme was the 
first saccharifying enzyme to be studied in detail. 
The N-terminal region of lysozyme showed 
similarity to a region in CBH I from position 129 
onwards. It is interesting to note that ,& 
glucosidase, xylanase and lysozyme show 
homology around the same region of both CBH I 
and endo II. The complete DNA sequence of the 
CBH I gene has been published [2] and an intron 
was found between residue 132 and 133. More se- 
Sequence work both on the protein and DNA 
side is in progress on cellulases and this work in- 
dicates that lots of interesting findings regarding 
structure and genetic relations among cellulases 
and other saccharifying enzymes are to be 
expected. 
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